Good to see some buying coming in. Market definitely not pricing this correctly. Currently with an EV of $35m and minimum first year revenues of ~$6-8m, looks like a steal at these levels.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come